ATE312626T1 - Mucoadhäsive, wärmeaktivierbare zubereitung als träger für medikamente - Google Patents
Mucoadhäsive, wärmeaktivierbare zubereitung als träger für medikamenteInfo
- Publication number
- ATE312626T1 ATE312626T1 AT03001453T AT03001453T ATE312626T1 AT E312626 T1 ATE312626 T1 AT E312626T1 AT 03001453 T AT03001453 T AT 03001453T AT 03001453 T AT03001453 T AT 03001453T AT E312626 T1 ATE312626 T1 AT E312626T1
- Authority
- AT
- Austria
- Prior art keywords
- mucoadhesive
- carrier
- activatable
- medications
- preparation
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 230000003232 mucoadhesive effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- 229920002807 Thiomer Polymers 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021032564A CN1224424C (zh) | 2002-02-01 | 2002-02-01 | 粘膜吸附性的热凝性医药载体组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312626T1 true ATE312626T1 (de) | 2005-12-15 |
Family
ID=4739817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03001453T ATE312626T1 (de) | 2002-02-01 | 2003-01-22 | Mucoadhäsive, wärmeaktivierbare zubereitung als träger für medikamente |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1332764B1 (de) |
| CN (1) | CN1224424C (de) |
| AT (1) | ATE312626T1 (de) |
| DE (1) | DE60302676T2 (de) |
| DK (1) | DK1332764T3 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006009764A1 (en) | 2004-06-17 | 2006-01-26 | Amano Enzyme Usa., Ltd. | Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers |
| WO2006039659A1 (en) * | 2004-10-02 | 2006-04-13 | Sri International | Bioadhesive delivery system for transmucosal delivery of beneficial agents |
| WO2006133349A2 (en) * | 2005-06-08 | 2006-12-14 | Alpharma, Inc. | Orally disintegrable sleep aid formulations |
| RU2013147883A (ru) * | 2011-04-01 | 2015-05-10 | Юниверсити Оф Флорида Рисеч Фаундэйшн, Инк. | Термочувствительные, мукоадгезивные или кожно-адгезивные и усиливающие проникновение композиции для местной доставки терапевтических средств |
| CN103405769A (zh) | 2013-03-07 | 2013-11-27 | 北京亿仁赛博医疗科技研发中心有限公司 | 光敏剂在制备治疗疾病的病毒灭活药物中的应用 |
| CN103432581A (zh) | 2013-03-22 | 2013-12-11 | 北京海思威科技有限公司 | 速立氧注射剂在制备治疗疾病的病毒灭活中的应用 |
| AR100864A1 (es) * | 2014-06-09 | 2016-11-09 | Klox Tech Inc | Composiciones biofotónicas termoendurecibles y sus usos |
| ITUB20152862A1 (it) * | 2015-08-05 | 2017-02-05 | Teres Srl | Veicolo per terapia fotodinamica topica con acido delta-aminolevulinico in ambito dermatologico e metodo di preparazione del veicolo stesso. |
| CN105534739A (zh) * | 2015-12-31 | 2016-05-04 | 杭州惠康医疗器械有限公司 | 一种复合凝胶 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0551626A1 (de) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible Gel als pharmazeutische Grundmasse für eine galenische Form |
-
2002
- 2002-02-01 CN CNB021032564A patent/CN1224424C/zh not_active Expired - Lifetime
-
2003
- 2003-01-22 DE DE60302676T patent/DE60302676T2/de not_active Expired - Lifetime
- 2003-01-22 AT AT03001453T patent/ATE312626T1/de not_active IP Right Cessation
- 2003-01-22 EP EP03001453A patent/EP1332764B1/de not_active Expired - Lifetime
- 2003-01-22 DK DK03001453T patent/DK1332764T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP1332764B1 (de) | 2005-12-14 |
| EP1332764A1 (de) | 2003-08-06 |
| DK1332764T3 (da) | 2006-05-01 |
| DE60302676T2 (de) | 2006-09-07 |
| CN1224424C (zh) | 2005-10-26 |
| CN1435261A (zh) | 2003-08-13 |
| DE60302676D1 (de) | 2006-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200302214T4 (tr) | Psoriasis tedavisi için kullanilan pteridine bileşkenleri | |
| CY1107899T1 (el) | 6.αλφα., 9.αλφα. - διφθορο-17.αλφα.-(2-φουρανυλοανθρακοξυλικο) οξυ-11.βητα.-υδροξυ-16.αλφα.-μεθυλο-3-οξο-ανδροστα-1,4-διενιο-17-ανθρακοθειϊκο οξυ s-φθορομεθυλο εστερας ως αντιφλεγμονωδης παραγοντας | |
| BR9914638A (pt) | Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| PT1003504E (pt) | Compostos quimicos | |
| PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
| BR0001254A (pt) | Composição que compreende pelo menos um composto bicìclico aromático, utilização da composição e processo de solubilização de um composto bicìclico aromático | |
| NO20014415D0 (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
| NL300176I1 (nl) | Esters van 5-aminolevulinezuur als fotosensibiliserende middelen in de fotochemotherapie. | |
| DK1137762T3 (da) | Behandling af Pompes sygdom | |
| EE200100558A (et) | Triarüülhappe derivaat, seda sisaldav farmatseutiline kompositsioon ja ühendi raviotstarbeline kasutamine | |
| DE60126980D1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| TR200401029T4 (tr) | Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları | |
| ATE194987T1 (de) | Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden | |
| BR0206495A (pt) | Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato | |
| ATE312626T1 (de) | Mucoadhäsive, wärmeaktivierbare zubereitung als träger für medikamente | |
| EE200400031A (et) | Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat | |
| BR0209128A (pt) | Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
| DE69707372D1 (de) | Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne | |
| CY1111900T1 (el) | Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda) | |
| IT1307786B1 (it) | Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali. | |
| BR0206087A (pt) | Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias | |
| DK0853476T3 (da) | Nimesulidholdigt farmaceutisk præparat til topisk anvendelse | |
| BR0007183A (pt) | Isonipectoamidas para o tratamento de distúrbios mediados por integrina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |